{"id":"W4390767843","doi":"10.1016/j.eclinm.2023.102405","title":"Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial","year":2024,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Aeglea BioTherapeutics","keywords":"Medicine; Placebo; Double blind; Arginase; Randomized controlled trial; Placebo-controlled study; Physical therapy; Internal medicine; Alternative medicine; Pathology; Arginine; Biochemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002862835,0.0002959319,0.001161962,0.0001755673,0.00004208119,0.00002176341,0.000203081,0.0002360007,0.0001281611],"category_scores_gemma":[0.001846932,0.0002158933,0.0002881046,0.0002426766,0.0004919554,0.000006045925,0.0001053283,0.0002582419,0.00001297844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004268968,"about_ca_system_score_gemma":0.0001992397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003548848,"about_ca_topic_score_gemma":0.00004298302,"domain_scores_codex":[0.9971064,0.000339121,0.001266116,0.0006751357,0.0002574227,0.0003557761],"domain_scores_gemma":[0.9985464,0.0005605167,0.0001807735,0.0004454028,0.00006349628,0.000203367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9874327,0.001351519,0.00006543499,0.00009890965,0.0001437838,0.00003415806,0.0002059631,0.0000354121,0.001533258,0.0003673256,0.0007014635,0.008030039],"study_design_scores_gemma":[0.9854795,0.0006863746,0.00003486418,0.0001468,0.0003265118,0.000008688435,0.0001303528,0.001580636,0.0005193809,0.00005208006,0.01081754,0.0002173096],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9495815,0.04152712,0.001937548,0.001474924,0.0007899415,0.003576432,0.00002779721,0.00002110964,0.001063623],"genre_scores_gemma":[0.9901927,0.007230198,0.0006334109,0.0002260757,0.0004598201,0.0001293664,0.0001487733,0.00003199442,0.0009477155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04061114,"threshold_uncertainty_score":0.8803875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02784344415186302,"score_gpt":0.355487212634591,"score_spread":0.327643768482728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}